You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cll/Small Lymphocytic Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • TQB3909 tablet
  • Zhengzhou, Henan, China
  • +1 more
Jul 17, 2023

Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Whittier, California
    Innovative Clinical Research Institute
Aug 8, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Nagoya-shi, Aichi, Japan
    • +19 more
    Jan 25, 2023

    Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

    Not yet recruiting
    • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
      • (no location specified)
      Dec 16, 2022

      Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

      Active, not recruiting
      • Contiguous Stage II Small Lymphocytic Lymphoma
      • +11 more
      • MOR00208
      • +2 more
      • Columbus, Ohio
        The Ohio State University Comprehensive Cancer Center
      Feb 24, 2022

      Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

      Not yet recruiting
      • Autoimmune Hemolytic Anemia
      • +3 more
      • Ibrutinib 420 mg
      • (no location specified)
      Jan 12, 2023

      Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

      Recruiting
      • CLL/SLL
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital Affiliate
      Jun 16, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)

      Not yet recruiting
      • B-cell Lymphoma
      • +7 more
      • CTX112
      • (no location specified)
      Dec 12, 2022

      Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

      Active, not recruiting
      • Leukemia
      • Lymphoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 11, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023

      Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

      Active, not recruiting
      Has Results
      • Small Lymphocytic Lymphoma
      • CLL (Chronic Lymphocytic Leukemia)
      • Fludarabine Phosphate
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 13, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Not yet recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 10, 2023

      Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

      Completed
      • Lymphoid Leukemia
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Jan 30, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Dec 5, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • 5:2 Method (intermittent fasting regimen)
      • 16/8 Method (intermittent fast regimen)
      • Victoria, British Columbia, Canada
        Eleah Stringer
      Feb 2, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • (no location specified)
      Nov 30, 2022

      Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

      Completed
      Has Results
      • Follicular Lymphoma (FL/Indolent NHL)
      • +4 more
      • Huntsville, Alabama
      • +22 more
      Apr 1, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Duarte, California
      • +2 more
      Oct 7, 2022